Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 31 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 16, 2023 Filed Aug 17, 2023 23:57 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Exercise / conversionCommon Shares | 1,142 | $71.43 | $81,573.06 |
DisclosureSEC source: 0000721371-23-000078 · wf-form4_169231666604167.xml · nonDerivative · entry 3 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:57 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
GrantCommon Shares | 13,274 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000078 · wf-form4_169231666604167.xml · nonDerivative · entry 2 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,563 F3 · kind: Grant of RSUs that vest in three equal annual installments beginning on August 15, 2024. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:54 UTC |
Scherer Mary C.Chief Accounting Officer
|
GrantCommon Shares | 1,659 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000074 · wf-form4_169231644293717.xml · nonDerivative · entry 2 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,884 F3 · kind: Grant of RSUs that vest in three equal annual installments beginning on August 15, 2024. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:56 UTC |
Hollar Jason M.Chief Executive Officer
|
GrantCommon Shares | 53,097 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000076 · wf-form4_169231656320810.xml · nonDerivative · entry 2 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,811 F3 · kind: Grant of RSUs that vest in three equal annual installments beginning on August 15, 2024. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:52 UTC |
Mason Stephen MCEO, Medical Segment
|
GrantCommon Shares | 13,274 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000072 · wf-form4_169231635388699.xml · nonDerivative · entry 2 Mason Stephen M · CIK 0001786065 · CEO, Medical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,855 F3 · kind: Grant of RSUs that vest in three equal annual installments beginning on August 15, 2024. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:51 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
GrantCommon Shares | 15,487 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000070 · wf-form4_169231625163130.xml · nonDerivative · entry 2 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,202 F3 · kind: Grant of RSUs that vest in three equal annual installments beginning on August 15, 2024. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:49 UTC |
Greene Michelle D.Chief Information Officer
|
GrantCommon Shares | 10,398 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000068 · wf-form4_169231616625890.xml · nonDerivative · entry 2 Greene Michelle D. · CIK 0001945228 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,814 F3 · kind: Grant of restricted share units RSUs that vest in three equal annual installments beginning on August 15, 2024. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:47 UTC |
Snow Ola MChief Human Resources Officer
|
GrantCommon Shares | 9,956 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000066 · wf-form4_169231603006162.xml · nonDerivative · entry 2 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,179 F3 · kind: Grant of RSUs that vest in three equal annual installments beginning on August 15, 2024. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:45 UTC |
Alt Aaron EChief Financial Officer
|
GrantCommon Shares | 16,593 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000064 · wf-form4_169231592137861.xml · nonDerivative · entry 1 Alt Aaron E · CIK 0001741576 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,319 F1 · kind: Grant of restricted share units that vest in three equal annual installments beginning on August 15, 2024. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 23:57 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Tax withholdingCommon Shares | 20,010 | $92.99 | $1,860,729.90 |
DisclosureSEC source: 0000721371-23-000078 · wf-form4_169231666604167.xml · nonDerivative · entry 1 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,289 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 16,282 restricted share units ("RSUs") and 28,329 performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 23:54 UTC |
Scherer Mary C.Chief Accounting Officer
|
Tax withholdingCommon Shares | 2,852 | $92.99 | $265,207.48 |
DisclosureSEC source: 0000721371-23-000074 · wf-form4_169231644293717.xml · nonDerivative · entry 1 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,225 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 3,804 restricted share units ("RSUs") and 2,552 performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 23:56 UTC |
Hollar Jason M.Chief Executive Officer
|
Tax withholdingCommon Shares | 20,771 | $92.99 | $1,931,495.29 |
DisclosureSEC source: 0000721371-23-000076 · wf-form4_169231656320810.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,714 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 41,409 restricted share units ("RSUs") and 38,282 performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 23:52 UTC |
Mason Stephen MCEO, Medical Segment
|
Tax withholdingCommon Shares | 25,701 | $92.99 | $2,389,935.99 |
DisclosureSEC source: 0000721371-23-000072 · wf-form4_169231635388699.xml · nonDerivative · entry 1 Mason Stephen M · CIK 0001786065 · CEO, Medical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,581 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 19,018 restricted share units ("RSUs") and 38,282 performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 23:51 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Tax withholdingCommon Shares | 10,966 | $92.99 | $1,019,728.34 |
DisclosureSEC source: 0000721371-23-000070 · wf-form4_169231625163130.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,715 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 11,908 restricted share units ("RSUs") and 12,760 performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 23:49 UTC |
Greene Michelle D.Chief Information Officer
|
Tax withholdingCommon Shares | 1,239 | $92.99 | $115,214.61 |
DisclosureSEC source: 0000721371-23-000068 · wf-form4_169231616625890.xml · nonDerivative · entry 1 Greene Michelle D. · CIK 0001945228 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,416 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 2,682 restricted share units ("RSUs"). F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 23:47 UTC |
Snow Ola MChief Human Resources Officer
|
Tax withholdingCommon Shares | 15,031 | $92.99 | $1,397,732.69 |
DisclosureSEC source: 0000721371-23-000066 · wf-form4_169231603006162.xml · nonDerivative · entry 1 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,223 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 11,129 restricted share units ("RSUs") and 22,969 performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:48 UTC |
Snow Ola MChief Human Resources Officer
|
GrantCommon Shares | 22,969 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000054 · wf-form4_169153847319351.xml · nonDerivative · entry 3 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,254 F2 · kind: Reflects performance share units that will settle on August 15, 2023. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:45 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 813 | $51.49 Strike: $51.49 | $41,861.37 |
DisclosureSEC source: 0000721371-23-000050 · wf-form4_169153829553871.xml · derivative · entry 4 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 813 shares Expires 2023-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option, representing a right to purchase 2,440 shares, became exercisable in three equal annual installments beginning on August 15, 2014, which was the first anniversary of the date on which the option was granted. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:45 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Tax withholdingCommon Shares | 618 | $91.25 | $56,392.50 |
DisclosureSEC source: 0000721371-23-000050 · wf-form4_169153829553871.xml · nonDerivative · entry 3 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,299 F2 · kind: No shares were sold in this transaction. Reflects surrender of shares to satisfy the exercise price and tax withholding obligations due upon exercise of a stock option that was to expire on August 15, 2023. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:45 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Exercise / conversionCommon Shares | 813 | $51.49 | $41,861.37 |
DisclosureSEC source: 0000721371-23-000050 · wf-form4_169153829553871.xml · nonDerivative · entry 2 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:45 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
GrantCommon Shares | 28,329 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000050 · wf-form4_169153829553871.xml · nonDerivative · entry 1 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,104 F1 · kind: Reflects performance share units that will settle on August 15, 2023. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:42 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
GrantCommon Shares | 12,760 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000048 · wf-form4_169153814884060.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,681 F1 · kind: Reflects performance share units that will settle on August 15, 2023. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:40 UTC |
Mason Stephen MCEO, Medical Segment
|
GrantCommon Shares | 38,282 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000046 · wf-form4_169153804106253.xml · nonDerivative · entry 1 Mason Stephen M · CIK 0001786065 · CEO, Medical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,282 F1 · kind: Reflects performance share units that will settle on August 15, 2023. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:38 UTC |
Hollar Jason M.Chief Executive Officer
|
GrantCommon Shares | 38,282 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000044 · wf-form4_169153791366200.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,485 F1 · kind: Reflects performance share units that will settle on August 15, 2023. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:36 UTC |
Scherer Mary C.Chief Accounting Officer
|
GrantCommon Shares | 2,552 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000042 · wf-form4_169153777957699.xml · nonDerivative · entry 1 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,077 F1 · kind: Reflects performance share units that will settle on August 15, 2023. Read SEC document |
| May 15, 2023 Filed May 17, 2023 13:12 UTC |
Hollar Jason M.Chief Executive Officer
|
Tax withholdingCommon Shares | 3,037 | $84.77 | $257,446.49 |
DisclosureSEC source: 0000721371-23-000029 · wf-form4_168432914039495.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,203 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 6,810 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:28 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Tax withholdingCommon Shares | 1,336 | $70.72 | $94,481.92 |
DisclosureSEC source: 0000721371-23-000018 · wf-form4_167899850716618.xml · nonDerivative · entry 1 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,775 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 2,984 restricted share units. F2 · price: Reflects closing price on prior business day. F3 · balance_after: The total number of shares reported as beneficially owned has been adjusted to reflect shares transferred pursuant to a domestic relations order. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:26 UTC |
Greene Michelle D.Chief Information Officer
|
Tax withholdingCommon Shares | 669 | $70.72 | $47,311.68 |
DisclosureSEC source: 0000721371-23-000016 · wf-form4_167899837202535.xml · nonDerivative · entry 1 Greene Michelle D. · CIK 0001945228 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,655 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 1,437 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 21:16 UTC |
Alt Aaron EChief Financial Officer
|
GrantCommon Shares | 12,726 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000011 · wf-form4_167658218904919.xml · nonDerivative · entry 1 Alt Aaron E · CIK 0001741576 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,726 F1 · kind: Grant of restricted share units that vest in three equal annual installments beginning on February 15, 2024. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:29 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Tax withholdingCommon Shares | 380 | $80.17 | $30,464.60 |
DisclosureSEC source: 0000721371-22-000176 · wf-form4_167027574558242.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,921 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:27 UTC |
Snow Ola MChief Human Resources Officer
|
Tax withholdingCommon Shares | 596 | $80.17 | $47,781.32 |
DisclosureSEC source: 0000721371-22-000174 · wf-form4_167027561381407.xml · nonDerivative · entry 1 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,961 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| November 21, 2022 Filed Aug 8, 2023 23:46 UTC |
DOWNEY BRUCEDirector
|
GiftCommon Shares | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000052 · wf-form5_169153838293516.xml · nonDerivative · entry 1 DOWNEY BRUCE · CIK 0001237257 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,729 Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 21:19 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Tax withholdingCommon Shares | 5,185 | $75.21 | $389,963.85 |
DisclosureSEC source: 0000721371-22-000172 · wf-form4_166863354625915.xml · nonDerivative · entry 1 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,827 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 11,560 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 21:13 UTC |
Brennan MichelleDirector
|
PurchaseCommon Shares | 200 | $74.72 | $14,944.00 |
DisclosureSEC source: 0000721371-22-000170 · wf-form4_166863316364612.xml · nonDerivative · entry 2 Brennan Michelle · CIK 0001827353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,324 Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 21:13 UTC |
Brennan MichelleDirector
|
PurchaseCommon Shares | 200 | $76.30 | $15,260.00 |
DisclosureSEC source: 0000721371-22-000170 · wf-form4_166863316364612.xml · nonDerivative · entry 1 Brennan Michelle · CIK 0001827353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,124 Read SEC document |
| November 10, 2022 Filed Nov 10, 2022 21:36 UTC |
Brennan MichelleDirector
|
PurchaseCommon Shares | 150 | $79.74 | $11,961.00 |
DisclosureSEC source: 0000721371-22-000164 · wf-form4_166811615215819.xml · nonDerivative · entry 2 Brennan Michelle · CIK 0001827353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,924 Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:41 UTC |
Chandrasekaran SujathaDirector
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000168 · wf-form4_166811644987135.xml · nonDerivative · entry 1 Chandrasekaran Sujatha · CIK 0001734598 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,774 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:38 UTC |
Hall Patricia HemingwayDirector
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000166 · wf-form4_166811630150459.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,502 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:36 UTC |
Brennan MichelleDirector
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000164 · wf-form4_166811615215819.xml · nonDerivative · entry 1 Brennan Michelle · CIK 0001827353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,774 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:33 UTC |
DOWNEY BRUCEDirector
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000162 · wf-form4_166811599108843.xml · nonDerivative · entry 1 DOWNEY BRUCE · CIK 0001237257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,929 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:30 UTC |
Barg StevenDirector
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000160 · wf-form4_166811580030156.xml · nonDerivative · entry 1 Barg Steven · CIK 0001852883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,774 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:27 UTC |
Evans David CDirector
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000158 · wf-form4_166811563289361.xml · nonDerivative · entry 1 Evans David C · CIK 0001375909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,611 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:25 UTC |
COX CARRIE SMITHDirector
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000156 · wf-form4_166811550524579.xml · nonDerivative · entry 1 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,631 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:22 UTC |
KENNY GREGORY BDirector
|
GrantCommon Shares | 3,867 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000154 · wf-form4_166811532810416.xml · nonDerivative · entry 1 KENNY GREGORY B · CIK 0001179497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,487 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:20 UTC |
Edison Sheri H.Director
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000152 · wf-form4_166811517778628.xml · nonDerivative · entry 1 Edison Sheri H. · CIK 0001413612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,086 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:17 UTC |
MUNDKUR CHRISTINEDirector
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000150 · wf-form4_166811502160602.xml · nonDerivative · entry 1 MUNDKUR CHRISTINE · CIK 0001237264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,774 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:15 UTC |
Killefer NancyDirector
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000148 · wf-form4_166811490047105.xml · nonDerivative · entry 1 Killefer Nancy · CIK 0001584637 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,862 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:12 UTC |
JOHRI AKHILDirector
|
GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000146 · wf-form4_166811474249561.xml · nonDerivative · entry 1 JOHRI AKHIL · CIK 0001517450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,106 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:20 UTC |
Snow Ola MChief Human Resources Officer
|
GiftCommon Shares | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000142 · wf-form4_166802878657113.xml · nonDerivative · entry 2 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,557 Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:20 UTC |
Snow Ola MChief Human Resources Officer
|
SaleCommon Shares | 19,590 | $78.87 | $1,545,063.30 |
DisclosureSEC source: 0000721371-22-000142 · wf-form4_166802878657113.xml · nonDerivative · entry 1 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,187 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.